Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder—murine Pompe diseaseNina Raben, Paul H. Plötz, Cynthia Schreiner et al.|Autophagy|2010Cited by 160
Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapyNina Raben, Paul H. Plötz, Yin‐Hsiu Chien et al.|Molecular Genetics and Metabolism|2010Cited by 74
Fiber Type Conversion by PGC-1α Activates Lysosomal and Autophagosomal Biogenesis in Both Unaffected and Pompe Skeletal MuscleShoichi Takikita, Nina Raben, Rebecca Baum et al.|PLoS ONE|2010Cited by 61
When more is less: Excess and deficiency of autophagy coexist in skeletal muscle in Pompe diseaseNina Raben, Paul H. Plötz, Rebecca Baum et al.|Autophagy|2009Cited by 59
The values and limits of an in vitro model of Pompe disease: The best laid schemes o’ mice an’ men ……..<sup>†</sup>Shoichi Takikita, Paul H. Plötz, Rachel Myerowitz et al.|Autophagy|2009Cited by 16